Global Antivertigo Agents Market, By Drug Class (Antihistamines, Phenothiazines, Anticholinergics, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Antivertigo Agents Market Analysis and Size
The global antivertigo agents market is expected to witness significant growth during the forecast period. The factors boosted the growth of antivertigo agents market are rise in vertigo cases as well as viral infections, brain injury, and heart conditions all over the globe and vulnerable aging population would influence the demand of antivertigo agents. Developing markets and huge investment in research and development are the factors responsible for the growth of this market.
Data Bridge Market Research analyses a growth rate in the global antivertigo agents market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Antivertigo agents are a type of pharmacological agent that suppress vestibular signals from the semi-circular canals and thus causes reduction in the episodes of vertigo, thereby relieving or alleviating symptoms of vertigo. Common symptoms of vertigo are sweating, nausea, walking impairment, balance problems and many others.
Antivertigo Agents Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Drug Class (Antihistamines, Phenothiazines, Anticholinergics, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Novartis AG (Switzerland), Endo International Inc (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (India), Cipla Inc (India), Dr Reddy's Laboratories Ltd (India), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc (U.S.), Zydus Group (India), Lupin (India), Vintage Labs (India), Abbvie Inc. (U.S.) |
|
Market Opportunities |
|
Global Antivertigo Agents Market Dynamics
Drivers
- Prevalence of Cases of Vertigo
Vertigo is a very common issue. Approximately 40 percent of Americans experience symptoms of vertigo at least once during their lifetime. Vertigo and dizziness are common symptoms in the general population, with an projected prevalence between 20% and 56%. This boosts market growth.
- Rising Demand for Oral Drugs
Oral medications are predicted to accelerate market expansion. Since the majority of the products are available in capsule and tablet form and are a very practical route of administration, the segment is anticipated to accelerate the global market.
Opportunities
- Rise in Elderly Population
According to research, elderly population is more prone to suffer from this disease. According to the Aging World reports from 2015, there were approximately 562 million people 65 and older worldwide, which increased the disease's incidence and fueled the growth of the cubital tunnel syndrome market.
- Increasing Demand for Retail Pharmacies
Opportunities for market growth are created by the increase in the therapeutic anti-vertigo agents being delivered through retail pharmacies as well as the rise in the number of retail pharmacies in developed nations. Patients also support retail pharmacies because they are convenient for purchasing medications.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global anti vertigo agents market over a forecast period.
- High Cost
The huge expenditure associated with antivertigo agents medications surely hamper the market growth.
This global antivertigo agents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global antivertigo agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Antivertigo Agents Market
In light of the current situation, COVID-19 has caused an unprecedented global public health crisis that has a bearing on almost every industry. Its long-term effects are anticipated to have an impact on industry growth over the course of the forecast period. Clinical trial delays and the transition of healthcare infrastructure to managing COVID-19 have resulted in the cancellation of drug launches.
Due to the demand for a COVID-19 vaccine and treatment medications in the post-pandemic era, the biotechnology and pharmaceutical industries are anticipated to experience tremendous future growth. Thus, this will significantly impact the antivertigo agents market.
Global Antivertigo Agents Market Scope
The global antivertigo agents market is segmented on the basis of drug class, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug Class
- Antihistamines
- Phenothiazines
- Anticholinergics
- Others
Route of Administration
- Oral
- Parenteral
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Antivertigo Agents Market Regional Analysis/Insights
The global antivertigo agents market is analysed and market size insights and trends are provided by drug class, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global antivertigo agents market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing positive growth for global antivertigo agents market throughout the forecasted period due to the rise cases of vertigo and increase in awareness about the exact causes of vertigo as well as advanced healthcare facilities.
Asia-Pacific dominates the market due to the increase government initiatives and developing healthcare facilities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Antivertigo Agents Market Share Analysis
The global antivertigo agents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global antivertigo agents market
Key players operating in the global antivertigo agents market include:
- Novartis AG (Switzerland)
- Endo International Inc (Ireland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Glenmark Pharmaceuticals Ltd (India)
- Cipla Inc (India)
- Dr Reddy's Laboratories Ltd (India)
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Pfizer Inc (U.S.)
- Zydus Group (India)
- Lupin (India)
- Vintage Labs (India)
- Abbvie Inc. (U.S.)
SKU-
